FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103702484> ?p ?o ?g. }

• W2103702484 endingPage "238" @default.
• W2103702484 startingPage "233" @default.
• W2103702484 abstract "Background Recombinant human erythropoietin (rhEPO) is used for the treatment of anemia of prematurity. However, it has also been found to have properties similar to vascular endothelial growth factor (VEGF), the major angiogenic factor implicated in the pathogenesis of retinopathy of prematurity (ROP). We sought to determine whether rhEPO is an independent risk factor for the development of ROP. Methods Data were analyzed from 264 infants admitted to the Loma Linda University Children's Hospital neonatal intensive care unit in 1994 and 2002. The data included demographic characteristics, incidence of major morbidities, rhEPO treatment, number of red blood cell transfusions received, and incidence and severity of ROP. A multiple logistic regression model was used to determine the relation of the studied risk factors to the incidence (any stage) and severity (threshold ROP requiring cryotherapy or laser photocoagulation) of ROP. Results The risk of developing ROP increased among infants who received >20 doses of rhEPO was higher compared with those who received ≤20 doses (OR, 3.53; 95% CI, 1.59, 7.85). These infants were also more likely to require laser photocoagulation (OR, 4.31; 95% CI, 1.99, 9.33). The age at which rhEPO was started was also a significant risk factor, with those starting rhEPO after 20 days of age having almost fourfold the risk of ROP compared with those starting it on or before 20 days of age (OR, 3.57; 95% CI, 1.59, 8.03). Conclusions rhEPO was found to be a significant independent risk factor for the development of ROP. Recombinant human erythropoietin (rhEPO) is used for the treatment of anemia of prematurity. However, it has also been found to have properties similar to vascular endothelial growth factor (VEGF), the major angiogenic factor implicated in the pathogenesis of retinopathy of prematurity (ROP). We sought to determine whether rhEPO is an independent risk factor for the development of ROP. Data were analyzed from 264 infants admitted to the Loma Linda University Children's Hospital neonatal intensive care unit in 1994 and 2002. The data included demographic characteristics, incidence of major morbidities, rhEPO treatment, number of red blood cell transfusions received, and incidence and severity of ROP. A multiple logistic regression model was used to determine the relation of the studied risk factors to the incidence (any stage) and severity (threshold ROP requiring cryotherapy or laser photocoagulation) of ROP. The risk of developing ROP increased among infants who received >20 doses of rhEPO was higher compared with those who received ≤20 doses (OR, 3.53; 95% CI, 1.59, 7.85). These infants were also more likely to require laser photocoagulation (OR, 4.31; 95% CI, 1.99, 9.33). The age at which rhEPO was started was also a significant risk factor, with those starting rhEPO after 20 days of age having almost fourfold the risk of ROP compared with those starting it on or before 20 days of age (OR, 3.57; 95% CI, 1.59, 8.03). rhEPO was found to be a significant independent risk factor for the development of ROP." @default.
• W2103702484 created "2016-06-24" @default.
• W2103702484 creator A5001176686 @default.
• W2103702484 creator A5037867922 @default.
• W2103702484 creator A5040227879 @default.
• W2103702484 creator A5049426576 @default.
• W2103702484 creator A5069964128 @default.
• W2103702484 creator A5079770665 @default.
• W2103702484 creator A5082124234 @default.
• W2103702484 creator A5083109293 @default.
• W2103702484 creator A5087477660 @default.
• W2103702484 date "2008-06-01" @default.
• W2103702484 modified "2023-10-11" @default.
• W2103702484 title "Human recombinant erythropoietin and the incidence of retinopathy of prematurity: A multiple regression model" @default.
• W2103702484 cites W1507203673 @default.
• W2103702484 cites W1536635467 @default.
• W2103702484 cites W1595913608 @default.
• W2103702484 cites W189180901 @default.
• W2103702484 cites W1899050407 @default.
• W2103702484 cites W1910536265 @default.
• W2103702484 cites W1965134002 @default.
• W2103702484 cites W1969082248 @default.
• W2103702484 cites W1969973923 @default.
• W2103702484 cites W1980830278 @default.
• W2103702484 cites W1995673954 @default.
• W2103702484 cites W1996849092 @default.
• W2103702484 cites W1998581885 @default.
• W2103702484 cites W2003085598 @default.
• W2103702484 cites W2015163828 @default.
• W2103702484 cites W2016841730 @default.
• W2103702484 cites W2020701166 @default.
• W2103702484 cites W2024986103 @default.
• W2103702484 cites W2028190897 @default.
• W2103702484 cites W2036100553 @default.
• W2103702484 cites W2037517553 @default.
• W2103702484 cites W2041543062 @default.
• W2103702484 cites W2057301128 @default.
• W2103702484 cites W2064048040 @default.
• W2103702484 cites W2066126762 @default.
• W2103702484 cites W2069429592 @default.
• W2103702484 cites W2072839085 @default.
• W2103702484 cites W2080684014 @default.
• W2103702484 cites W2080917464 @default.
• W2103702484 cites W2081787251 @default.
• W2103702484 cites W2088255586 @default.
• W2103702484 cites W2092588760 @default.
• W2103702484 cites W2112352997 @default.
• W2103702484 cites W2112915598 @default.
• W2103702484 cites W2125806058 @default.
• W2103702484 cites W2132252436 @default.
• W2103702484 cites W2136512906 @default.
• W2103702484 cites W2145090990 @default.
• W2103702484 cites W2165673197 @default.
• W2103702484 cites W2267265391 @default.
• W2103702484 cites W4248231685 @default.
• W2103702484 cites W4252686797 @default.
• W2103702484 cites W4292489196 @default.
• W2103702484 cites W4319308506 @default.
• W2103702484 cites W66883936 @default.
• W2103702484 doi "https://doi.org/10.1016/j.jaapos.2007.08.009" @default.
• W2103702484 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18589385" @default.
• W2103702484 hasPublicationYear "2008" @default.
• W2103702484 type Work @default.
• W2103702484 sameAs 2103702484 @default.
• W2103702484 citedByCount "76" @default.
• W2103702484 countsByYear W21037024842012 @default.
• W2103702484 countsByYear W21037024842013 @default.
• W2103702484 countsByYear W21037024842014 @default.
• W2103702484 countsByYear W21037024842015 @default.
• W2103702484 countsByYear W21037024842016 @default.
• W2103702484 countsByYear W21037024842017 @default.
• W2103702484 countsByYear W21037024842018 @default.
• W2103702484 countsByYear W21037024842019 @default.
• W2103702484 countsByYear W21037024842020 @default.
• W2103702484 countsByYear W21037024842021 @default.
• W2103702484 countsByYear W21037024842022 @default.
• W2103702484 crossrefType "journal-article" @default.
• W2103702484 hasAuthorship W2103702484A5001176686 @default.
• W2103702484 hasAuthorship W2103702484A5037867922 @default.
• W2103702484 hasAuthorship W2103702484A5040227879 @default.
• W2103702484 hasAuthorship W2103702484A5049426576 @default.
• W2103702484 hasAuthorship W2103702484A5069964128 @default.
• W2103702484 hasAuthorship W2103702484A5079770665 @default.
• W2103702484 hasAuthorship W2103702484A5082124234 @default.
• W2103702484 hasAuthorship W2103702484A5083109293 @default.
• W2103702484 hasAuthorship W2103702484A5087477660 @default.
• W2103702484 hasConcept C120665830 @default.
• W2103702484 hasConcept C121332964 @default.
• W2103702484 hasConcept C126322002 @default.
• W2103702484 hasConcept C141071460 @default.
• W2103702484 hasConcept C151956035 @default.
• W2103702484 hasConcept C187212893 @default.
• W2103702484 hasConcept C2777091541 @default.
• W2103702484 hasConcept C2778248108 @default.
• W2103702484 hasConcept C2778376644 @default.
• W2103702484 hasConcept C2778534260 @default.
• W2103702484 hasConcept C2779234561 @default.
• W2103702484 hasConcept C2779918416 @default.

• next